Piper Sandler analyst Adam Maeder lowered the firm’s price target on Intuitive Surgical (ISRG) to $575 from $670 and keeps an Overweight rating on the shares. The firm notes the company reported a strong Q1 ahead of consensus on both the top and bottom-line. Additionally, management raised its FY2025 procedure guidance from +13%-16% year-over-year to +15%-17%, which is indicative of the underlying momentum.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical price target lowered to $575 from $600 at Baird
- Intuitive Surgical: Strong Performance and Growth Potential Amidst Challenges
- Intuitive Surgical Reports Strong Q1 2025 Earnings
- Closing Bell Movers: Tesla jumps on Musk plans to pare back his DOGE work
- Intuitive Surgical sees FY25 capital expenditures $650M-$750M